✦ LIBER ✦

Liver transplantation for hepatocellular carcinoma: The hepatitis C quandary

✍ Scribed by Francis Y. Yao

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 63 KB
Volume: 13
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.21062

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Liver transplantation for hepatocellular

Liver transplantation for hepatocellular carcinoma

✍ C.-M. Lo; S.-T. Fan 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 3 views

Liver transplantation for hepatocellular

Liver transplantation for hepatocellular carcinoma

✍ Alan P. Venook 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB 👁 1 views

Background: Liver transplantation for unresectable hepatocellular carcinoma yields disappointing results. Most cases recur within 2 years, often in the transplanted liver. Methods: A combination of neoadjuvant doxorubicin and orthotopic liver transplantation was used in 20 patients with unresectable

Predictors of survival after liver trans

Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C

✍ Mitsugi Shimoda; Rafik M. Ghobrial; Ian C. Carmody; Dean M. Anselmo; Douglas G. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 1 views

The efficacy of orthotopic liver transplantation (OLT) for hepatocellular carcinoma (HCC) associated with hepatitis C virus (HCV) is not well defined. This study examines the variables that may determine the outcome of OLT for HCC in HCV patients. From 1990 to 1999, 463 OLTs were performed for HCV c

Liver transplantation for hepatocellular

Liver transplantation for hepatocellular carcinoma: The MELD impact

✍ Pratima Sharma; Vijayan Balan; Jose L. Hernandez; Ann M. Harper; Erick B. Edward 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 1 views

The new allocation policy of the United Network of Organ Sharing (UNOS) based on the model for end-stage liver disease (MELD) gives candidates with stage T1 or stage T2 hepatocellular carcinoma (HCC) a priority MELD score beyond their degree of hepatic decompensation. The aim of this study was to de

Liver transplantation for non–hepatocell

Liver transplantation for non–hepatocellular carcinoma malignancies

✍ Gregory J. Gores; Julie K. Heimbach; Charles B. Rosen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

## Key Points 1. Hepatic epithelioid hemangioendothelioma is a rare disease with a variable natural history; current data support liver transplantation for unresectable disease. 2. Anti-vascular endothelial cell growth factor therapy may change the approach to hepatic epithelioid hemangioendotheli

Preoperative hepatic artery chemoemboliz

Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma

✍ Harnois, Denise M. ;Steers, Jeffery ;Andrews, James C. ;Rubin, Joseph C. ;Pitot, 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 111 KB

In our experience, the primary obstacle precluding the widespread use of orthotopic liver transplantation (OLT) for definitive therapy of hepatocellular carcinoma (HCC), even for early-stage disease, is preventing tumor recurrence. Chemoembolization is an attractive strategy to minimize tumor progre